PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-155

  1. 121 Posts.
    lightbulb Created with Sketch. 31
    I cant agree with you more on that point, the word hope is thrown around far too much in the webinars, and here we are, now in a position of hoping. It would be nice if we had sufficient funds, a board and a commercial partner, alass that is the risk we all take with a bio play, if it were that easy, there wouldnt be such an upside. Good discussion though, I like it. We can kick it off again in a few months, and one of us can hopefully say, I told you so.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.